Valdoxan Patient Program

In November 2019, Kos designed, developed, and implemented the Valdoxan Patient Program with Servier Laboratories (Aust) Pty Ltd). Servier has partnered with PharmaPrograms to provide the Program which supports patients prescribed Valdoxan (agomelatine) tablets. This medication is a private prescription-only medicine used to treat depression in adults including to prevent relapse.